Ceridian rises with capital infusion; Zayo better on paydown; Blount revises tranching

By Sara Rosenberg

New York, March 31 – Ceridian’s term loan strengthened in trading on Thursday in reaction to news of an additional capital investment, and Zayo Group LLC saw its term loan B inch higher following word of a loan repayment with proceeds from an upsized bond offering.

Ceridian’s term loan B-2 was quoted at 96¾ bid, 97¾ offered, up from 93 bid, 95 offered, a trader said.

Zayo Group’s term loan B was quoted at 99 5/8 bid, 100 1/8 offered, up an eighth of a point on the day, a trader said. The company’s B-2 term loan was unchanged at 100¼ bid, 100¾ offered.

Moving to the primary market, Blount International Inc. increased the size of its U.S. term loan and removed the euro term loan from its proposed capital structure.

Also, Premiere Global Services Inc., ERT (eResearchTechnology Inc.), NAPA Management Services Corp. (NMSC Holdings Inc.) and Evoqua Water Technologies (EWT Holdings III Corp.) came out with price talk on their new deals.

In addition, MKS Instruments Inc. disclosed timing on the launch of its proposed credit facility, and American Renal Holdings Inc. and MGM Growth Properties Operating Partnership LP joined this week’s new issue calendar.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.